Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Nomenclature01:17

Drug Nomenclature

During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that the same...
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Pharmaceutical Equivalents01:26

Pharmaceutical Equivalents

As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical outcomes associated with anti-CD38-based retreatment in relapsed/refractory multiple myeloma: a systematic literature review.

Frontiers in oncology·2025
Same author

Expert consensus on the benefits of neuraminidase in conventional influenza vaccines: a Delphi study.

BMC infectious diseases·2025
Same author

Systematic literature review on early clinical evidence for immune-resolution therapies and potential benefits to patients and healthcare providers.

Frontiers in immunology·2024
Same author

Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systematic Literature Review.

International journal of chronic obstructive pulmonary disease·2023
Same author

AbobotulinumtoxinA Doses in Upper and Lower Limb Spasticity: A Systematic Literature Review.

Toxins·2022
Same author

Epidemiological and clinical burden associated with plexiform neurofibromas in pediatric neurofibromatosis type-1 (NF-1): a systematic literature review.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2021

Related Experiment Video

Updated: Jul 9, 2026

Formation of Dispersible Taohong Siwu Tablets
05:44

Formation of Dispersible Taohong Siwu Tablets

Published on: February 3, 2023

The pharmaceutical industry as an informant.

Joe Collier1, Ike Iheanacho

  • 1Medicines Policy Unit, Department of Pharmacology and Clinical Pharmacology, St George's Hospital Medical School, SW17 0RE, London, UK. jcollier@sghms.ac.uk

Lancet (London, England)
|November 9, 2002
PubMed
Summary

The pharmaceutical industry prioritizes medical information over drug production, influencing healthcare practices. This commercially driven information, often confidential, can sometimes conflict with patient and societal interests.

Keywords:
Biomedical and Behavioral ResearchHealth Care and Public Health

More Related Videos

An Improved Technique for Trimethylamine Detection in Animal-Derived Medicine by Headspace Gas Chromatography-Tandem Quadrupole Mass Spectrometry
04:19

An Improved Technique for Trimethylamine Detection in Animal-Derived Medicine by Headspace Gas Chromatography-Tandem Quadrupole Mass Spectrometry

Published on: March 10, 2023

Application of DNA Barcoding to Identify Medicinal Plants
08:55

Application of DNA Barcoding to Identify Medicinal Plants

Published on: November 1, 2024

Related Experiment Videos

Last Updated: Jul 9, 2026

Formation of Dispersible Taohong Siwu Tablets
05:44

Formation of Dispersible Taohong Siwu Tablets

Published on: February 3, 2023

An Improved Technique for Trimethylamine Detection in Animal-Derived Medicine by Headspace Gas Chromatography-Tandem Quadrupole Mass Spectrometry
04:19

An Improved Technique for Trimethylamine Detection in Animal-Derived Medicine by Headspace Gas Chromatography-Tandem Quadrupole Mass Spectrometry

Published on: March 10, 2023

Application of DNA Barcoding to Identify Medicinal Plants
08:55

Application of DNA Barcoding to Identify Medicinal Plants

Published on: November 1, 2024

Area of Science:

  • Pharmaceutical industry
  • Medical information management
  • Healthcare economics

Background:

  • The pharmaceutical sector invests heavily in generating, collecting, and distributing medical information, often exceeding resources allocated to drug manufacturing.
  • This medical information serves critical functions, including aiding drug development, meeting regulatory and patent requirements, supporting sales, and informing healthcare professionals and patients.

Purpose of the Study:

  • To analyze the significant resource allocation towards medical information within the pharmaceutical industry.
  • To examine the dual role of this information as both a developmental resource and a commercial asset.
  • To evaluate the impact of commercially driven information dissemination on clinical practice and patient welfare.

Main Methods:

  • Qualitative analysis of industry practices regarding medical information.
  • Review of regulatory and intellectual property frameworks governing pharmaceutical data.
  • Assessment of the influence of transnational pharmaceutical companies on healthcare.

Main Results:

  • Pharmaceutical companies dedicate substantial resources to medical information management, often surpassing drug production investments.
  • Commercial interests heavily influence the creation and dissemination of medical information, which is frequently confidential and proprietary.
  • The management and dissemination of pharmaceutical information can impact clinical practice, with potential conflicts between commercial goals and public health interests.

Conclusions:

  • The pharmaceutical industry's focus on information management is a critical aspect of its operations, driven by commercial and regulatory imperatives.
  • Confidentiality and commercial interests in pharmaceutical information can create challenges in ensuring transparency and optimal patient care.
  • Further examination is needed to balance the commercial value of pharmaceutical information with the need for accessible, unbiased data to safeguard patient and societal well-being.